GFAP and Alzheimer disease: This hypothesis is also supported by recent findings by Bellaver and colleagues who showed that astrocyte reactivity measured by elevated GFAP levels is an important upstream event linking Aβ deposition in the brain with accumulation of tau pathology in individuals at risk for AD (37).